Kemin Pharma Biotherapeutic Targets Clostridium Difficile, An Acute And Severe Hospital Infection
Fri, 07 Jul 2006 06:00 AM EST
... Researchers at Kemin Pharmaannounce a significant breakthrough in the treatment of Clostridiumdifficile associated diarrhea (CDAD), the most common form ofantibiotic-associated diarrhea among hospital and long-term care facilitypatients. [click link for full article] ...
Related Topics
- Clostridium Difficile Infection
- Infection Control
- Acute Care
- Hospital
- Health Facilities
- Colitis
- Severe Acute Respiratory Syndrome (SARS)
- Bacterial Infection
- Bacterial Infections
- Fungal Infections & Diseases
- Fungal Infections
- Ear Infections
- Yeast Infections
- Infections
- Infection (bladder)
- Infection (kidney)
- Vaginal Infections
- Viral Infections
- Urinary Tract Infection
- Urinary Tract Infections

Not Signed In -


